JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, MARCH 3, 2020
Media advisory: The full study and related articles are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.0146?guestAccessKey=81dbd6bd-caf2-4c0a-8919-333413227b46&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030320
What The Study Did: What the pharmaceutical and health product industry spent on lobbying and contributions to political campaigns in the U.S. from 1999 to 2018 was the focus of this observational study that used federal- and state-level data. This study is part of a theme issue from JAMA on drug pricing.
Author: Olivier J. Wouters, Ph.D., of the London School of Economics and Political Science, is the corresponding author.
Editor’s Note: Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.